SAGES white paper on antibiotic omission in the management of acute uncomplicated diverticulitis: why, when, who, and most importantly, how
- PMID: 40263135
- DOI: 10.1007/s00464-025-11738-w
SAGES white paper on antibiotic omission in the management of acute uncomplicated diverticulitis: why, when, who, and most importantly, how
Abstract
Background: Historically, the management of acute uncomplicated diverticulitis was centered on antibiotics. However, modern theories regarding the pathogenesis of diverticulitis have challenged the notion that antibiotics are necessary in all cases. Despite major reform in many societal guidelines, the adoption of non-antibiotic therapy for uncomplicated diverticulitis has been limited, especially in North America. The purpose of this SAGES White Paper was to review the available evidence on antibiotic omission in uncomplicated diverticulitis and to explore methods of safe implementation.
Methods: A task force within the SAGES Colorectal Surgery Committee was formed to work on this White Paper. The committee and its leadership approved an outline that would focus on the following topics: (1) Defining the problem with unnecessary antibiotic exposure; (2) Evaluating the evidence on antibiotic omission in uncomplicated diverticulitis; (3) Identifying the appropriate patient for antibiotic omission; (4) Outlining how to counsel patients who are treated without antibiotics; (5) Reviewing methods to safely implement this practice in both the hospital and community setting. These topics were divided up among members of the task force who performed a structured literature search in preparation for their assignments.
Results: Antibiotics are associated with several patient and societal adverse effects, including the rising problem of antimicrobial resistance. Randomized controlled trials have demonstrated no superiority to the routine administration of antibiotics in acute uncomplicated diverticulitis. Appropriate patients for antibiotic omission include those who are immunocompetent, non-septic, and have mild symptoms/disease severity on imaging. Existing frameworks for the safe implementation of new practices can be referenced to help increase adoption of non-antibiotic therapy.
Conclusion: The existing body of evidence supports antibiotic omission in appropriate cases of acute uncomplicated diverticulitis. In order to increase the widespread adoption of this practice, buy-in from key stakeholders (both healthcare professionals and patients) is necessary.
Keywords: Antibiotics; Evidence; SAGES; Uncomplicated diverticulitis; White paper.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Disclosures: Authors Richard Garfinkle, Robert D. Bennett, Siva Dantu, Alessandra Gasior, Alexander T. Hawkins, Jessica Holland, Ana Sofia Ore, Virginia Shaffer, James Taylor, and Elisabeth C. McLemore have no relevant disclosures or conflicts of interest. Patricia Sylla is a consultant for Activ Surgical, Stryker, Ethicon, Safeheal, and Exero. Marylise Boutros receives a speakers honorarium from Johnson and Johnson.
Similar articles
-
Antibiotics for uncomplicated diverticulitis.Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD009092. doi: 10.1002/14651858.CD009092.pub3. Cochrane Database Syst Rev. 2022. PMID: 35731704 Free PMC article.
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Delayed antibiotic prescriptions for respiratory infections.Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD004417. doi: 10.1002/14651858.CD004417.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Oct 4;10:CD004417. doi: 10.1002/14651858.CD004417.pub6. PMID: 28881007 Free PMC article. Updated.
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical